There are an abundance of topical antibiotics that enter the ophthalmic market as a conjunctivitis indication and demonstrate effective proficiency. The author has no relevant affiliations or ...

Most of the antibiotic development for systemic therapy is for the treatment of Gram-positive infections such as MRSA and vancomycin-resistant Enterococcus. In ophthalmology, the interest is not ...